Line 81: | Line 81: | ||
<li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Viability">Viability</a></li> | <li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Viability">Viability</a></li> | ||
<li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Wound_Care">Wound Care</a></li> | <li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Wound_Care">Wound Care</a></li> | ||
− | <li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Integrated_Bacteriocins"> | + | <li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Integrated_Bacteriocins">Integrated Bacteriocins</a></li> |
<li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Biosensing">Biosensing</a></li> | <li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Biosensing">Biosensing</a></li> | ||
<li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Bandage_Design">Bandage Design</a></li> | <li><a href="https://2018.igem.org/Team:TU-Eindhoven/AD/Bandage_Design">Bandage Design</a></li> |
Revision as of 09:33, 1 October 2018